arterial hypertension (HTA) It continues to be one of the main worldwide cardiovascular risk factors, affecting millions of people and representing a significant cause of adverse events such as myocardial infarction, stroke and renal damage. In the search to optimize the control of this condition, las…

Randomized controlled clinical trials have shown a reduction in heart failure (IC) of the 50% o más con el tratamiento antihipertensivo1. The mechanisms for the prevention of HF are explained by the prevention of myocardial infarction, prevention and regression of left ventricular hypertrophy (WHI) durante…

In December 2023 The European Hypertension Society published an extensive guide to help clinicians to diagnose, Stratify and treat this condition. It is unquestionable that the document has constituted a valuable contribution in this field. However, un aspecto que se ha prestado para la controversia ha…